Hetero Labs Limited, Unit-IX – 09/26/2025. Country: India. Record Type: 483
Similar Posts
Promotional Labeling and Advertising Considerations for Prescription Biological Reference Products, Biosimilar Products, and Interchangeable Biosimilar Products: Questions and Answers
The guidance addresses questions that manufacturers, packers, distributors, and their representatives (firms) may have when developing FDA-regulated promotional labeling and advertisements for prescription reference products, biosimilar products, and interchangeable biosimilar products.Carrot Top Kitchens of Bridgeport (formerly Redding) Issues a Class II Recall of Hummus Containing Undeclared Sesame
HARTFORD — The Connecticut Department of Consumer Protection Food and Standards Division is warning the public that Carrot Top Country Kitchens LLC, DBA Carrot Top Kitchens of Bridgeport (formerly Redding), is recalling 5 varieties of hummus due to undeclared sesame.Activities Report of the Generic Drug Program (FY 2025) – FDARA Title VIII Sections 807 and 805
Section 807 of the FDA Reauthorization Act of 2017 (FDARA) requires the FDA to report on certain abbreviated new drug applications (ANDAs).PDUFA and BsUFA Quarterly Hiring Updates
PDUFA and BsUFA Quarterly Hiring UpdatesSun Pharmaceuticals Medicare Ltd. 9/19/2025
Record Date: 9/19/2025
Entity Name: Sun Pharmaceuticals Medicare Ltd.
FEI Number: 3002957541
Record Type: 483
Country: India
Establishment Type: Sterile Drug Manufacturer